Miochol-E 20 mg Powder and solvent for instillation solution for intraocular use
PDF Leaflet Revision Date: 04 September 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Rapid miosis during anterior segment surgery.
Dosage (summary)
0.5 to 2 mu2113 for satisfactory miosis.
Onset of Action / Duration
Onset: seconds, Duration: short.
Special Populations
- Children
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Anticholinesterases
- Beta blockers
- NSAIDs
Contraindications
- Hypersensitivity to acetylcholine
- Intestinal obstruction
- Asthma
- Cardiovascular disorders
- Pregnancy
Common side effects
- Corneal oedema
- Bradycardia
- Hypotension
Counselling Points
- Prepare solution immediately before use
- Do not re-sterilize
- Discard unused solution
Serious warnings
- Caution in systemic conditions
- Use only after lens delivery in cataract surgery
Important Disclaimer
The Miochol-E 20 mg Powder and solvent for instillation solution for intraocular use professional information leaflet below is the property of Soflens and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
